Unknown NA INTERVENTIONAL 3-arm NCT03218579

Endoscopic Assessment and Prediction of Microbiome-modifying Interventions (microbiome)

Sponsor: Tel-Aviv Sourasky Medical Center

Conditions Antibiotic Side Effect Gut Microbiome

Interventions Bacteriotherapy Probiotic treatment

Updated 5 times since 2017 Last updated: Jul 18, 2017 Started: Feb 1, 2013 Primary completion: Dec 30, 2019 Completion: Dec 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03218579, this NA trial focuses on Antibiotic Side Effect and Gut Microbiome and remains ongoing. Sponsored by Tel-Aviv Sourasky Medical Center, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2018 — Jan 2021 [monthly]

Recruiting NA
Aug 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Feb 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tel-Aviv Sourasky Medical Center
Weizmann Institute of Science

Data source: Tel-Aviv Sourasky Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tel Aviv, Israel